Analysis of the clinical efficacy of different doses of ambroxol inhalation in the treatment of chronic bronchitis
氨溴索不同剂量雾化吸入治疗慢性支气管炎临床疗效分析

摘要

目的 治疗慢性支气管炎时探讨采用氨溴索不同剂量的临床效果。方法 采用分组对比的研究方法，与2020年8月－2021年8月从本院中选取符合研究要求的80例慢性支气管炎患者，将其以40例每组的方法平均分到采用小剂量雾化吸入的参照组和采用大剂量雾化吸入的研究组，记录组间产生的相关数据进行比较。结果 研究组临床效果高于参照组，生活质量高于参照组（P＜0.05）。结论 大剂量雾化吸入氨溴索用于治疗慢性支气管炎效果显著，对患者生活质量的改善有良好作用。

Abstract

Objective: To explore the clinical effects of different doses of ambroxol in the treatment of chronic bronchitis. Method: Using the research method of group comparison, 80 patients with chronic bronchitis who meet the research requirements were selected from this hospital from August 2020 to August 2021, and 40 patients in each group were equally divided into small doses. The reference group of nebulized inhalation and the study group of high-dose nebulized inhalation, recorded the relevant data generated between the groups for comparison.
Results: The clinical effect of the study group was higher than that of the reference group, and the quality of life was higher than that of the reference group (P<0.05).
Conclusion  : High-dose aerosol inhalation of ambroxol is effective for the treatment of chronic bronchitis and has a good effect on improving the quality of life of patients.